Clinical Trial: Clinical Efficacy and Immunological Mechanisms of Telitacicept in the Treatment of Sjögren’s Disease Complicated with Interstitial Lung Disease (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Efficacy and Immunological Mechanisms of Telitacicept in the Treatment of Sjögren’s Disease Complicated with Interstitial Lung Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130591

Registration Time: 2026/08/21

Type: Observational study

Primary Sponsor: Peking University People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330807

Published by HT Digital Content Services with permission from Health Daily Digest....